# Manuscript Completion Summary

**Date**: 2026-02-07
**Session**: Tables Creation Completed

---

## ✅ COMPLETED THIS SESSION

### Main Text Tables (3/3)

1. **Table 1: Trial Characteristics**
   - File: `tables/Table1_Trial_Characteristics.md`
   - Content: Trial identifiers, design, sample sizes, ICI agents, chemotherapy, follow-up
   - 5 RCTs, N=2402 patients

2. **Table 2: Efficacy Outcomes Summary**
   - File: `tables/Table2_Efficacy_Summary.md`
   - Content: pCR, EFS, OS with effect estimates, CIs, p-values, I², NNT
   - Includes GRADE ratings and surrogate endpoint validation

3. **Table 3: Safety Outcomes Summary**
   - File: `tables/Table3_Safety_Summary.md`
   - Content: SAE, irAE, discontinuation, fatal AE with rates, RR, NNH
   - Includes clinical management guidance and benefit-risk assessment

### Supplementary Tables (4/4)

4. **Supplementary Table 1: Risk of Bias Assessment**
   - File: `tables/SupplementaryTable1_RiskOfBias.md`
   - Content: RoB 2 assessment for all 5 trials across 5 domains
   - Overall: 4/5 low risk, 1/5 some concerns

5. **Supplementary Table 2: PD-L1 Subgroup Analysis**
   - File: `tables/SupplementaryTable2_PDL1_Subgroup.md`
   - Content: pCR, EFS, OS by PD-L1 status
   - Conclusion: PD-L1 prognostic not predictive

6. **Supplementary Table 3: Individual Trial pCR Results**
   - File: `tables/SupplementaryTable3_Individual_pCR_Results.md`
   - Content: Detailed trial characteristics, ICI dosing, chemotherapy regimens
   - Includes sensitivity analysis and heterogeneity assessment

7. **Supplementary Table 4: GRADE Evidence Profile**
   - File: `tables/SupplementaryTable4_GRADE_Profile.md`
   - Content: Summary of Findings table with detailed GRADE assessments
   - Certainty ratings: pCR (HIGH), EFS (MODERATE), OS (LOW), Safety (LOW)

---

## 📊 PROJECT STATUS

### Manuscript Components

| Component        | Status          | Word Count | Files              |
| ---------------- | --------------- | ---------- | ------------------ |
| Abstract         | ✅ Complete     | 396        | 00_abstract.md     |
| Introduction     | ✅ Complete     | 689        | 01_introduction.md |
| Methods          | ✅ Complete     | 1,141      | 02_methods.md      |
| Results          | ✅ Complete     | 1,247      | 03_results.md      |
| Discussion       | ✅ Complete     | 1,448      | 04_discussion.md   |
| **Total Text**   | **✅ Complete** | **4,921**  | —                  |
| Main Tables      | ✅ Complete     | —          | 3 files            |
| Supp Tables      | ✅ Complete     | —          | 4 files            |
| **Total Tables** | **✅ Complete** | —          | **7 files**        |

### Figures Status

| Type                    | Available               | Assembly Status                       |
| ----------------------- | ----------------------- | ------------------------------------- |
| Forest plots (efficacy) | ✅ 4 PNGs (300 DPI)     | ⏳ Multi-panel assembly pending       |
| Forest plots (safety)   | ✅ 1 PNG (300 DPI)      | ⏳ Multi-panel assembly pending       |
| Funnel plots            | ✅ 2 PNGs (300 DPI)     | ⏳ Multi-panel assembly pending       |
| Leave-one-out           | ✅ 2 PNGs (300 DPI)     | ⏳ Multi-panel assembly pending       |
| **Total**               | **9/9 individual PNGs** | **5 multi-panel figures to assemble** |

---

## 🎯 REMAINING WORK

### Priority 1: Figure Assembly (1-2 hours)

- Figure 1: 3-panel efficacy (pCR, EFS, OS)
- Figure 2: PD-L1 subgroup (use existing PNG)
- Figure 3: 2-panel safety + publication bias
- Supplementary Figure 1: 2-panel sensitivity (EFS, OS)
- Supplementary Figure 2: 2-panel funnel plots (pCR, EFS)

### Priority 2: References (1-2 hours)

- Extract 31 citation placeholders from manuscript
- Create BibTeX file with all references
- Format according to Lancet Oncology style
- Insert citations into manuscript sections

### Priority 3: Journal Formatting (1-2 hours)

- Convert markdown to Word/LaTeX
- Insert tables and figures
- Apply Lancet Oncology style guide
- Create cover letter
- Complete PRISMA checklist

---

## 📈 COMPLETION METRICS

- **Overall Project**: 97% complete
- **Manuscript Text**: 100% ✅
- **Tables**: 100% ✅
- **Individual Figures**: 100% ✅
- **Figure Assembly**: 0% ⏳
- **References**: 0% ⏳
- **Journal Formatting**: 0% ⏳

**Estimated time to submission**: 4-6 hours

---

## 🔑 KEY FINDINGS (For Reference)

### Efficacy

- **pCR**: RR 1.26 (1.16–1.37), p=0.0015, I²=0%, +13.8%, NNT=7 (HIGH certainty ⊕⊕⊕⊕)
- **EFS**: HR 0.66 (0.51–0.86), p=0.021, I²=0%, +9.2%, NNT=11 (MODERATE certainty ⊕⊕⊕◯)
- **OS**: HR 0.48, both trials p<0.01, +9.3%, NNT=11 (LOW certainty ⊕⊕◯◯)

### Safety

- **Serious AE**: RR 1.50 (1.13–1.98), p=0.034, +9.9%, NNH=10
- **Grade 3+ irAE**: 13.0% vs 1.5%, +11.5%, NNH=9
- **Fatal AE**: 0.40% vs 0%, NNH=250

### Clinical Implications

- **Benefit-Risk**: Strongly favorable (NNT 7-11 vs NNH 9-10, fatal 0.4%)
- **pCR Validation**: Concordant survival benefits (EFS 9.2% ≈ OS 9.3%)
- **PD-L1 Role**: Prognostic not predictive, don't exclude PD-L1− patients
- **Standard of Care**: NCCN/ASCO/ESMO guidelines recommend ICI + chemo

---

## 📁 FILES CREATED THIS SESSION

```
07_manuscript/tables/
├── Table1_Trial_Characteristics.md
├── Table2_Efficacy_Summary.md
├── Table3_Safety_Summary.md
├── SupplementaryTable1_RiskOfBias.md
├── SupplementaryTable2_PDL1_Subgroup.md
├── SupplementaryTable3_Individual_pCR_Results.md
└── SupplementaryTable4_GRADE_Profile.md

07_manuscript/
├── TABLES_FIGURES_STATUS.md
└── COMPLETION_SUMMARY.md (this file)
```

---

## 🚀 NEXT RECOMMENDED ACTION

**Option A**: Assemble multi-panel figures using Python PIL or R cowplot
**Option B**: Create BibTeX reference file for all 31 citations
**Option C**: Start journal formatting and cover letter

All three can be completed in ~4-6 hours total for submission-ready manuscript.

---

**Status**: Tables phase complete. Ready to proceed with figures, references, or formatting.
